|
68
|
244
|
5l52B |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
58
|
204
|
5l5jI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
70
|
244
|
5l5oB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
58
|
222
|
5l5tL |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
50
|
250
|
5l4gC |
The human 26s proteasome at 3.9 a |
|
65
|
211
|
5l5uK |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
66
|
240
|
5l5aC |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
63
|
241
|
5l5fG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
57
|
204
|
5l5iI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
58
|
196
|
5l5oN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
58
|
196
|
5l5rN |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
69
|
233
|
5l54M |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
63
|
231
|
5l5pE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
66
|
250
|
5l5yA |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
70
|
243
|
5l5eF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
58
|
226
|
5l5aH |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
63
|
211
|
5l5qK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
|
63
|
231
|
5l5yE |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
46
|
238
|
5l4gF |
The human 26s proteasome at 3.9 a |
|
70
|
243
|
5l5hF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
69
|
243
|
5l5pF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
65
|
240
|
5l5pC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
56
|
204
|
5l55I |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
66
|
211
|
5l5pK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
70
|
243
|
5l5rF |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
41
|
199
|
5l4g2 |
The human 26s proteasome at 3.9 a |
|
70
|
243
|
5l5aF |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
67
|
242
|
5l5aD |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
57
|
204
|
5l5eI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
243
|
5l5iF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
69
|
242
|
5l5fD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
66
|
228
|
5l55M |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
59
|
222
|
5l5eL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
60
|
196
|
5l5eN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
68
|
242
|
5l5uD |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
60
|
196
|
5l54N |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
59
|
195
|
5l5oJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
250
|
5l5eA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
58
|
222
|
5l54H |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
71
|
244
|
5l5aB |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
62
|
222
|
5l5sL |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
44
|
199
|
5l4g6 |
The human 26s proteasome at 3.9 a |
|
62
|
222
|
5l5aL |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
63
|
231
|
5l5tE |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
42
|
233
|
5l4gB |
The human 26s proteasome at 3.9 a |
|
65
|
231
|
5l5iE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
68
|
250
|
5l5aA |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
66
|
250
|
5l5qA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
|
62
|
241
|
5l5iG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
69
|
243
|
5l5yF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
